Pharma Marketing Talk

Risk Mitigation and Its Impact on Pharma Marketing

Pharmaguy

Pharmaguy

Call in to speak with the host

(347) 996-5894

A conversation with Jeff Fetterman, President and CEO of ParagonRx, about developing a Risk Evaluation and Mitigation Strategy (REMS) that clinicians will consider useful and that would raise their intent to prescribe.
Tags:
pharmaceutical
marketing
ParagonRx
Drug Risk
REMS
Broadcast in Business
h:755
s:696598
archived

Comments

 comments